Taka
t-kahi.bsky.social
Taka
@t-kahi.bsky.social
in vitro pharmacologist/ pharmaceutical company / autoimmune disease/KNIME / High Content Analysis /CellProfiler/whisky / 創薬が興味の中心です
I’ve been working on building an in vitro evaluation system using human samples, and I finally got results that feel promising for use as a screening system.
August 15, 2025 at 1:58 PM
Had two whiskeys. So good.
April 25, 2025 at 1:40 PM
My first hike of the year!
April 19, 2025 at 5:33 AM
I recently received some valuable feedback about my work style.
When I have 10 tasks, I tend to push all of them forward, even if task #2 is clearly the most critical.
One of my strengths is having a broad view and managing multiple things at once.
April 11, 2025 at 4:01 AM
Reposted by Taka
ACPA specificity and recognition motifs were examined in 6,907 patients with RA from 5 Scandinavian cohorts. ACPA targeting non-glycine citrulline motifs assoc. more strongly w/ HLA-SE; ACPA to glycine citrulline motifs assoc. w/ smoking and IgA ACPA

A&R
doi.org/10.1002/art....
#Medsky #Immunosky
March 26, 2025 at 8:09 PM
Even if it’s just internal documents, always include sources for graphs and numbers. Otherwise, it’ll be difficult to review later or hand over to someone else.
March 16, 2025 at 7:57 AM
The Barking Crab

It was reasonably priced and delicious.
February 28, 2025 at 2:09 PM
I’m heading to Boston for a conference. I’m really looking forward to it!
February 24, 2025 at 1:42 AM
Generating ideas is important—it’s the first step of turning nothing into something. But I believe that developing and refining those ideas, taking them from start to finish, is even more valuable.
February 22, 2025 at 3:38 PM
Let’s not lose sight of our true goals and means. The purpose is to develop medicine, and we shouldn’t let that purpose turn into just a means to navigate corporate politics.
February 22, 2025 at 1:21 PM
I had a delicious meal and a great conversation with my colleague.
February 15, 2025 at 7:01 AM
Everyone wants to believe that the path they’ve chosen is the right one. And as long as they put in the effort to make it right for themselves, any path can become the right one
February 11, 2025 at 3:39 AM
My boss is fully committed to moving my project forward together. It helps me a lot.
February 8, 2025 at 2:43 AM
Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profiling

www.sciencedirect.com/science/arti...
Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profiling
Cancer research, cancer treatment, and the field of chemical biology are examples which heavily rely on the discovery of selective kinase inhibitors. …
www.sciencedirect.com
February 4, 2025 at 3:37 AM
IFN-γ–producing TH1 cells and dysfunctional regulatory T cells contribute to the pathogenesis of Sjögren’s disease

www.science.org/doi/10.1126/...
IFN-γ–producing TH1 cells and dysfunctional regulatory T cells contribute to the pathogenesis of Sjögren’s disease
Treg cell–specific deletion of Ca2+ influx results in a Sjögren’s disease–like phenotype in mice that is mediated by IFN-γ–producing CD4+ T cells.
www.science.org
February 3, 2025 at 10:47 PM
Serum Type I Interferon Score predicts clinically meaningful disease progression in limited cutaneous Systemic Sclerosis
acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
Serum Type I Interferon Score predicts clinically meaningful disease progression in limited cutaneous Systemic Sclerosis
Objective To assess the value of serum Type I Interferon (IFN) score in predicting clinically meaningful progression in limited cutaneous systemic sclerosis (lcSSc) using a novel composite endpoint ...
acrjournals.onlinelibrary.wiley.com
February 3, 2025 at 10:41 PM